FDA Approves First Oral Antiviral Drug to Treat COVID-19 in Adults
U.S. Food and Drug Administration
Paxlovid reduced the proportion of people with COVID-19-related hospitalization or death by 86 percent
Public Health
FDA Finalizes Individual Risk Assessment for Blood Donor Eligibility
U.S. Food and Drug Administration
All prospective blood donors will have to answer a series of individual, risk-based questions to determine eligibility
FDA Approves World’s First Respiratory Syncytial Virus (RSV) Vaccine
Swathi Kodaikal, MSc
A single dose of Arexvy reduced the risk of developing severe RSV-associated respiratory disease by 94.1 percent
Updated SHEA Guidance: Stop Antibiotics upon Closure of Incisions
Society for Healthcare Epidemiology of America
Medical organizations update strategies for preventing antimicrobial-resistant surgical site infections
Innovations in Diagnosing Antimicrobial Drug Resistance
Raeesa Gupte, PhD
Advances in sequencing, CRISPR-Cas diagnostics, and optical technology provide innovative alternatives to current AMR diagnostics
Cancer Risk Assessment with POC Genetic Testing Finds More Takers
Boston University School of Public Health
Offering digital cancer risk assessment with point-of-care testing more than doubled the average uptake of genetic testing
FDA Takes Additional Steps to Advance Decentralized Clinical Trials
U.S. Food and Drug Administration
Decentralizing clinical trials may improve accessibility, participant diversity
WHO Interim Survey: Health Systems Recover From Pandemic Aftereffects
World Health Organization
Number of countries with national supply chain system disruptions reduced from nearly half to about a quarter in just the last year
New Research Explores Role of Genetics in Opioid Use Disorder
University of Cincinnati
Study identifies genetic variants that could provide therapeutic targets in the future
FDA Approves First Orally Administered Fecal Microbiota Product to Prevent CDI Relapse
U.S. Food and Drug Administration
Fecal microbiota may aid in the restoration of the gut flora to prevent the recurrence of CDI
New York State Reported Record-High C. auris Cases in 2022
Swathi Kodaikal, MSc
Surveillance and clinical cases are at an all-time high in NY—a growing concern
Biomarker Pattern Found in Kids with COVID-19-Linked MIS-C
National Institutes of Health
Findings could lead to new means of diagnosis and treatment for multisystem inflammatory syndrome in children
Tackling the Rising Demand for Diagnostic Testing
Tracey Sainsbury, PhD
Planned efforts by stakeholders in the healthcare industry may resolve the challenges in diagnostic testing
Novel High Transmissibility Mechanism of Omicron Variant Revealed
The University of Hong Kong
First-ever, stable human organoid culture system from lung and nasal tissue helped study SARS-CoV-2 variant transmission
Leveraging Genomics in Tracking Infectious Diseases: Lessons from COVID-19
Trang Dahlen, MBA
Scalable solutions supporting workflow efficiency and accuracy are the need of the hour
Infectious SARS-CoV-2 Found in Hospital Air
University of Montreal Hospital Research Centre
Unique sample collection and cell culture methods may help analyze the airborne transmission of viruses
Artificial Pancreas Benefits Adults and Children with Diabetes
University of Virginia Health System
Average user spent 2.8 more hours per day in the target blood sugar range
FDA Amends EUAs to Simplify Use of Bivalent mRNA COVID-19 Vaccines
U.S. Food and Drug Administration
Unvaccinated individuals may receive a single dose of a bivalent vaccine, not multiple doses of the monovalent mRNA vaccines
Epidemiologists, Experts Review Mask Use Policy in Healthcare Settings
Mass General Brigham
Infectious diseases experts advocate for adapting universal masking requirements to changing conditions
FDA Approves Posttransplant Cell Therapy for Patients with Blood Cancers
U.S. Food and Drug Administration
Omisirge treatment hastens WBC recovery and reduces posttransplant disease risk but may cause adverse effects